MALT1 抑制剂用于治疗癌症和免疫疾病
1Smith, Gambrell & Russell LLP, 1105 West Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
ACS medicinal chemistry letters
|September 18, 2024
概括
介绍了用于治疗癌症和免疫疾病的新型MALT1抑制剂和药物成分. 这些化合物为这些疾病提供了新的治疗策略.
科学领域:
- 药用化学 医学化学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 粘膜关联淋巴组织淋巴瘤转位蛋白1 (MALT1) 是适应性免疫和B细胞恶性瘤的关键调节者.
- MALT1活动的失调与各种癌症和免疫疾病有关.
- 需要针对性治疗来调节MALT1功能.
研究的目的:
- 要披露MALT1.1的新型抑制剂.
- 为了呈现包含这些抑制剂的药物成分.
- 概述这些化合物的用于治疗癌症和免疫疾病的用途.
主要方法:
- 针对MALT1.1的新化学实体的合成和表征.
- 含有MALT1抑制剂的药物组合的配方.
- 在癌症和免疫疾病的临床前模型中评估治疗潜力.
主要成果:
- 强效和选择性MALT1抑制剂的鉴定.
- 在相关疾病模型中证明疗效.
- 建立合成路径用于化合物制备.
结论:
- 新型MALT1抑制剂代表着有前途的治疗药物.
- 这些化合物在瘤学和免疫学中有潜在的应用.
- 描述的药物成分和方法有助于其临床开发.
相关概念视频
Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
145
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


